Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2026-04-10 @ 2:21 AM
Study NCT ID:
NCT00579228
Status:
COMPLETED
Last Update Posted:
2023-09-14
First Post:
2007-12-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vascular Risk Progression in Normal and Diabetic Control Subjects.
Sponsor:
University of Nebraska
Organization:
Study Overview
Official Title:
Vascular Risk Progression in Normal and Diabetes Control Subjects
Status:
COMPLETED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to look at the progression of cardiovascular disease (CVD) in normal control individuals and in patients with controlled diabetes.
Detailed Description:
Cardiovascular disease remains the greatest cause of mortality in people with diabetes mellitus. This observation study will evaluate non-traditional risk factors for their contributions to vascular disease progression as determined by carotid intima media thickness and history of vascular disease events over 1 year. This study requires annual checks of blood, urine, history, and carotid ultrasound for carotid intimal medical thickness.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: